BioCentury | Sep 21, 2015
Clinical News

DiaPep277: Phase III data

...discovering alleged research misconduct during the DIA-AID 1 and 2 trials by employees of its Andromeda Biotech Ltd....
BioCentury | Mar 2, 2015
Company News

Hyperion Therapeutics Inc, Clal, Weizmann Institute of Science deal

...and alleged research misconduct during the DIA-AID 1 and 2 trials by employees of its Andromeda Biotech Ltd....
BioCentury | Oct 6, 2014
Finance

3Q14 Stock Wrap-Up: Going big again

...NASDAQ:HPTX) Hyperion discontinues development of diabetes candidate DiaPep277 following research misconduct. Hyperion says employees from Andromeda Biotech Ltd....
BioCentury | Sep 15, 2014
Finance

Highlights of weekly biotech stock moves

...misconduct related to the diabetes compound. Hyperion gained the product through its June acquisition of Andromeda Biotech Ltd....
BioCentury | Sep 15, 2014
Clinical News

DiaPep277: Development discontinued

...discovering research misconduct in development of the Type I diabetes product by employees of Hyperion's Andromeda Biotech Ltd....
BioCentury | Sep 10, 2014
Company News

Clal, Evotec fall on DiaPep277 revelations

...candidate DiaPep277 following alleged research misconduct. Hyperion gained the product through its June acquisition of Andromeda Biotech Ltd....
BioCentury | Sep 9, 2014
Company News

Scandal craters Hyperion's DiaPep277

...a move that comes just three months after Hyperion spent about $20.4 million to acquire Andromeda Biotech Ltd....
BioCentury | Jun 16, 2014
Company News

Clal, Hyperion deal

...Hyperion completed its acquisition of Clal's Andromeda Biotech Ltd. subsidiary for about $20.5 million in cash and stock...
BioCentury | Apr 28, 2014
Company News

Clal, Hyperion deal

...Hyperion will acquire Clal's Andromeda Biotech Ltd. subsidiary in a cash and stock deal. Clal will receive $12.5...
BioCentury | Apr 28, 2014
Finance

Highlights of weekly biotech stock moves

...Inc. (NASDAQ:HPTX) was off $0.32 to $24.39 last week after saying it will acquire the Andromeda Biotech Ltd....
Items per page:
1 - 10 of 30
BioCentury | Sep 21, 2015
Clinical News

DiaPep277: Phase III data

...discovering alleged research misconduct during the DIA-AID 1 and 2 trials by employees of its Andromeda Biotech Ltd....
BioCentury | Mar 2, 2015
Company News

Hyperion Therapeutics Inc, Clal, Weizmann Institute of Science deal

...and alleged research misconduct during the DIA-AID 1 and 2 trials by employees of its Andromeda Biotech Ltd....
BioCentury | Oct 6, 2014
Finance

3Q14 Stock Wrap-Up: Going big again

...NASDAQ:HPTX) Hyperion discontinues development of diabetes candidate DiaPep277 following research misconduct. Hyperion says employees from Andromeda Biotech Ltd....
BioCentury | Sep 15, 2014
Finance

Highlights of weekly biotech stock moves

...misconduct related to the diabetes compound. Hyperion gained the product through its June acquisition of Andromeda Biotech Ltd....
BioCentury | Sep 15, 2014
Clinical News

DiaPep277: Development discontinued

...discovering research misconduct in development of the Type I diabetes product by employees of Hyperion's Andromeda Biotech Ltd....
BioCentury | Sep 10, 2014
Company News

Clal, Evotec fall on DiaPep277 revelations

...candidate DiaPep277 following alleged research misconduct. Hyperion gained the product through its June acquisition of Andromeda Biotech Ltd....
BioCentury | Sep 9, 2014
Company News

Scandal craters Hyperion's DiaPep277

...a move that comes just three months after Hyperion spent about $20.4 million to acquire Andromeda Biotech Ltd....
BioCentury | Jun 16, 2014
Company News

Clal, Hyperion deal

...Hyperion completed its acquisition of Clal's Andromeda Biotech Ltd. subsidiary for about $20.5 million in cash and stock...
BioCentury | Apr 28, 2014
Company News

Clal, Hyperion deal

...Hyperion will acquire Clal's Andromeda Biotech Ltd. subsidiary in a cash and stock deal. Clal will receive $12.5...
BioCentury | Apr 28, 2014
Finance

Highlights of weekly biotech stock moves

...Inc. (NASDAQ:HPTX) was off $0.32 to $24.39 last week after saying it will acquire the Andromeda Biotech Ltd....
Items per page:
1 - 10 of 30